Cuizhe Wang

634 total citations
29 papers, 371 citations indexed

About

Cuizhe Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cuizhe Wang has authored 29 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Cuizhe Wang's work include Kruppel-like factors research (11 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Cuizhe Wang is often cited by papers focused on Kruppel-like factors research (11 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Cuizhe Wang collaborates with scholars based in China. Cuizhe Wang's co-authors include Jianxin Xie, Jun Zhang, Yajuan Gu, Peng Xu, Jingzhou Wang, Tingting Wang, Jiaojiao Zhu, Meixiu Zhang, Xin Yang and Bo Han and has published in prestigious journals such as The FASEB Journal, International Journal of Molecular Sciences and Journal of Lipid Research.

In The Last Decade

Cuizhe Wang

28 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuizhe Wang China 12 199 95 80 75 34 29 371
Mingyue Rao China 11 223 1.1× 85 0.9× 77 1.0× 41 0.5× 39 1.1× 18 400
Xianyi Liang China 5 212 1.1× 69 0.7× 120 1.5× 122 1.6× 53 1.6× 5 391
Jonathan C. Jaoude United States 7 232 1.2× 117 1.2× 44 0.6× 66 0.9× 55 1.6× 9 394
Gebo Wen China 14 278 1.4× 222 2.3× 83 1.0× 102 1.4× 53 1.6× 21 486
Yunfeng Hou China 12 216 1.1× 69 0.7× 36 0.5× 53 0.7× 27 0.8× 19 496
Marin E. Healy United States 5 160 0.8× 114 1.2× 71 0.9× 60 0.8× 19 0.6× 6 323
Shilu Luo China 13 307 1.5× 97 1.0× 99 1.2× 127 1.7× 18 0.5× 36 620
Yaqi Xing China 4 243 1.2× 93 1.0× 33 0.4× 64 0.9× 54 1.6× 7 425
Xiaoyang Shi China 13 273 1.4× 79 0.8× 86 1.1× 59 0.8× 112 3.3× 34 486
Xuewen Tian China 9 162 0.8× 44 0.5× 57 0.7× 47 0.6× 25 0.7× 34 320

Countries citing papers authored by Cuizhe Wang

Since Specialization
Citations

This map shows the geographic impact of Cuizhe Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuizhe Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuizhe Wang more than expected).

Fields of papers citing papers by Cuizhe Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuizhe Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuizhe Wang. The network helps show where Cuizhe Wang may publish in the future.

Co-authorship network of co-authors of Cuizhe Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cuizhe Wang. A scholar is included among the top collaborators of Cuizhe Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuizhe Wang. Cuizhe Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wei, Jin Mei, Xin Wen, et al.. (2025). Exosome-derived miR-548ag drives hepatic lipid accumulation via upregulating FASN through inhibition of DNMT3B. Journal of Lipid Research. 66(6). 100818–100818. 4 indexed citations
2.
Zhang, Lei, Menglin Zhang, Jinlong Huang, et al.. (2024). Klf9 is essential for cardiac mitochondrial homeostasis. Nature Cardiovascular Research. 3(11). 1318–1336. 4 indexed citations
3.
Wen, Xin, Jie Liu, Qianqian Wei, et al.. (2024). miR-548ag promotes DPP4 expression in hepatocytes through activation of TLR(7/8)/NF-κB pathway. International Journal of Obesity. 48(7). 941–953. 4 indexed citations
4.
Chen, Yao, et al.. (2024). Association of saturated fatty acids with cancer risk: a systematic review and meta-analysis. Lipids in Health and Disease. 23(1). 32–32. 28 indexed citations
5.
Wang, Jingzhou, Jie Liu, Keru Chen, et al.. (2024). Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer. BMC Cancer. 24(1). 75–75. 5 indexed citations
6.
Li, Menghuan, Yao Chen, Xin Wen, et al.. (2024). Palmitic acid promotes miRNA release from adipocyte exosomes by activating NF-κB/ER stress. Nutrition and Diabetes. 14(1). 75–75. 4 indexed citations
7.
Wang, Ruizhen, Xue Bai, Jingzhou Wang, et al.. (2024). Integrated analysis reveals that miR-548ab promotes the development of obesity and T2DM. Journal of genetics and genomics. 52(2). 231–244.
8.
Yang, Xin, et al.. (2023). KLF7 promotes adipocyte inflammation and glucose metabolism disorder by activating the PKCζ / NF‐κB pathway. The FASEB Journal. 37(7). e23033–e23033. 6 indexed citations
9.
Zhang, Meixiu, et al.. (2023). Stress-inducible IL-6 is regulated by KLF7 in brown adipocytes. Heliyon. 9(4). e14931–e14931. 4 indexed citations
10.
Zhang, Xueting, Menghuan Li, Jie Liu, et al.. (2023). Hepatic Glucose Metabolism Disorder Induced by Adipose Tissue-Derived miR-548ag via DPP4 Upregulation. International Journal of Molecular Sciences. 24(3). 2964–2964. 6 indexed citations
11.
Wang, Jingzhou, Qianqian Wei, Jie Liu, et al.. (2022). miR‐548ag functions as an oncogene by suppressing MOB1B in the development of obesity‐related endometrial cancer. Cancer Science. 114(4). 1507–1518. 5 indexed citations
12.
Yang, Xin, Jingzhou Wang, Jianxin Xie, et al.. (2022). Obesity-induced elevated palmitic acid promotes inflammation and glucose metabolism disorders through GPRs/NF-κB/KLF7 pathway. Nutrition and Diabetes. 12(1). 23–23. 33 indexed citations
13.
Liu, Shuang, Man Liu, Meng-Lin Zhang, et al.. (2022). Transcription factor Klf9 controls bile acid reabsorption and enterohepatic circulation in mice via promoting intestinal Asbt expression. Acta Pharmacologica Sinica. 43(9). 2362–2372. 6 indexed citations
14.
Li, Menghuan, Jingzhou Wang, Xin Yang, et al.. (2021). miR‐4431 targets TRIP10/PRKD1 and impairs glucose metabolism. Journal of Diabetes Investigation. 13(4). 617–627. 7 indexed citations
15.
Wang, Cuizhe, Jingzhou Wang, Jiaojiao Zhu, et al.. (2021). PA and OA induce abnormal glucose metabolism by inhibiting KLF15 in adipocytes. Nutrition & Metabolism. 18(1). 100–100. 5 indexed citations
16.
Zhu, Jiaojiao, Cuizhe Wang, Xueting Zhang, et al.. (2020). Correlation analysis of microribonucleic acid‐155 and microribonucleic acid‐29 with type 2 diabetes mellitus, and the prediction and verification of target genes. Journal of Diabetes Investigation. 12(2). 165–175. 12 indexed citations
17.
Wang, Cuizhe, Wei Li, Peng Xu, et al.. (2018). Comparative gene expression profile and DNA methylation status in diabetic patients of Kazak and Han people. Medicine. 97(36). e11982–e11982. 8 indexed citations
18.
Wang, Cuizhe, et al.. (2018). The Effect and Mechanism of TLR9/KLF4 in FFA-Induced Adipocyte Inflammation. Mediators of Inflammation. 2018. 1–10. 34 indexed citations
19.
Zhang, Meixiu, Cuizhe Wang, Xueting Zhang, et al.. (2018). The Effect and Mechanism of KLF7 in the TLR4/NF-κB/IL-6 Inflammatory Signal Pathway of Adipocytes. Mediators of Inflammation. 2018. 1–12. 34 indexed citations
20.
Wang, Cuizhe, Wei Li, Peng Xu, et al.. (2016). Correlation ofA2bARandKLF4/KLF15with Obesity-Dyslipidemia Induced Inflammation in Uygur Population. Mediators of Inflammation. 2016. 1–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026